rs72749169

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000069.3(CACNA1S):​c.5570G>A​(p.Ser1857Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00328 in 1,612,148 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0020 ( 1 hom., cov: 34)
Exomes 𝑓: 0.0034 ( 12 hom. )

Consequence

CACNA1S
NM_000069.3 missense

Scores

6
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: 3.42
Variant links:
Genes affected
CACNA1S (HGNC:1397): (calcium voltage-gated channel subunit alpha1 S) This gene encodes one of the five subunits of the slowly inactivating L-type voltage-dependent calcium channel in skeletal muscle cells. Mutations in this gene have been associated with hypokalemic periodic paralysis, thyrotoxic periodic paralysis and malignant hyperthermia susceptibility. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0077617764).
BP6
Variant 1-201039883-C-T is Benign according to our data. Variant chr1-201039883-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 254850.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-201039883-C-T is described in Lovd as [Benign]. Variant chr1-201039883-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00203 (309/152248) while in subpopulation NFE AF= 0.00368 (250/67988). AF 95% confidence interval is 0.0033. There are 1 homozygotes in gnomad4. There are 142 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 12 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1SNM_000069.3 linkc.5570G>A p.Ser1857Asn missense_variant Exon 44 of 44 ENST00000362061.4 NP_000060.2 Q13698
CACNA1SXM_005245478.4 linkc.5513G>A p.Ser1838Asn missense_variant Exon 43 of 43 XP_005245535.1 B1ALM3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1SENST00000362061.4 linkc.5570G>A p.Ser1857Asn missense_variant Exon 44 of 44 1 NM_000069.3 ENSP00000355192.3 Q13698

Frequencies

GnomAD3 genomes
AF:
0.00204
AC:
310
AN:
152130
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000434
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00169
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00369
Gnomad OTH
AF:
0.00239
GnomAD3 exomes
AF:
0.00211
AC:
528
AN:
250056
Hom.:
2
AF XY:
0.00217
AC XY:
293
AN XY:
135308
show subpopulations
Gnomad AFR exome
AF:
0.000985
Gnomad AMR exome
AF:
0.000665
Gnomad ASJ exome
AF:
0.0000994
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.00117
Gnomad NFE exome
AF:
0.00400
Gnomad OTH exome
AF:
0.00131
GnomAD4 exome
AF:
0.00341
AC:
4983
AN:
1459900
Hom.:
12
Cov.:
31
AF XY:
0.00336
AC XY:
2438
AN XY:
726378
show subpopulations
Gnomad4 AFR exome
AF:
0.000657
Gnomad4 AMR exome
AF:
0.000671
Gnomad4 ASJ exome
AF:
0.0000765
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000812
Gnomad4 FIN exome
AF:
0.00128
Gnomad4 NFE exome
AF:
0.00424
Gnomad4 OTH exome
AF:
0.00235
GnomAD4 genome
AF:
0.00203
AC:
309
AN:
152248
Hom.:
1
Cov.:
34
AF XY:
0.00191
AC XY:
142
AN XY:
74456
show subpopulations
Gnomad4 AFR
AF:
0.000433
Gnomad4 AMR
AF:
0.000719
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00169
Gnomad4 NFE
AF:
0.00368
Gnomad4 OTH
AF:
0.00237
Alfa
AF:
0.00362
Hom.:
2
Bravo
AF:
0.00198
TwinsUK
AF:
0.00539
AC:
20
ALSPAC
AF:
0.00363
AC:
14
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00372
AC:
32
ExAC
AF:
0.00187
AC:
227
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00316
EpiControl
AF:
0.00456

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:17
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

May 11, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 28259615, 30325262, 32859249) -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

CACNA1S: BS2 -

Feb 20, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Malignant hyperthermia, susceptibility to, 5 Benign:3
Sep 20, 2022
Color Diagnostics, LLC DBA Color Health
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 11, 2023
Genome-Nilou Lab
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 24, 2024
All of Us Research Program, National Institutes of Health
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hypokalemic periodic paralysis, type 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Apr 11, 2023
Genome-Nilou Lab
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Malignant hyperthermia, susceptibility to, 5;C2749982:Thyrotoxic periodic paralysis, susceptibility to, 1;C3714580:Hypokalemic periodic paralysis, type 1 Benign:1
Nov 08, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Malignant hyperthermia of anesthesia Benign:1
Aug 01, 2016
CSER _CC_NCGL, University of Washington
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: research

Found in patient having exome sequencing for an unrelated indication. No known history of Malignant hyperthermia. -

Congenital myopathy 18 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Thyrotoxic periodic paralysis, susceptibility to, 1 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Malignant hyperthermia, susceptibility to, 5;C3714580:Hypokalemic periodic paralysis, type 1 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0086
T;T
Eigen
Benign
-0.15
Eigen_PC
Benign
-0.050
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.74
T;T
M_CAP
Uncertain
0.087
D
MetaRNN
Benign
0.0078
T;T
MetaSVM
Uncertain
0.60
D
MutationAssessor
Benign
1.8
.;L
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.61
N;N
REVEL
Uncertain
0.34
Sift
Uncertain
0.0050
D;D
Sift4G
Benign
0.36
T;T
Polyphen
0.079
.;B
Vest4
0.058
MVP
0.93
MPC
0.11
ClinPred
0.027
T
GERP RS
4.5
Varity_R
0.17
gMVP
0.24

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs72749169; hg19: chr1-201009011; COSMIC: COSV99054152; COSMIC: COSV99054152; API